Intervention with homoeopathy in the management of breast cancer patient in reference to quality of life

Phase 3

Not yet recruiting

• Conditions: Malignant neoplasm of breast of unspecified site,

• Registration Number: CTRI/2022/12/047852

Brief Summary

- Over a period of 6 months all newpatients who chose treatment will be approached and includedin study, once they had given informed consent. Allpatients will receive the normalstandard of care offered in the institute.

- Thehomeopathic group will be offered a constitutional homeopathictreatment according to the principles ofclassical homeopathy accompanying or following conventionalcancer treatment.

- Ourprotocol stipulates that patient from both the conventionaland homeopathic cohort will be compared based onthe clinical data of tumour disease, staging and previous treatment.  In the observational study part all cancer patients -in adjuvant and in palliative stages - who will give theirinformed consent will be included.

- Comparison betweencomparable patients in both cohorts regarding their QoLas a feasibility study. We will bemeasuring patient self-reports, taken at study entry and every3 months over the course of one year.Medicalrecords will be taken by the treating physicians using case report forms(CRF).Patient records (CRFs) will be checked for completeness

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-12
• Last Update Posted: 2022-11-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

All types of Breast Cancer Patients ready to sign the consent form.

Exclusion Criteria

• No male patients 2.
• No patients below the age of 18 years and above 75 years 3.
• Patients unwilling to sign the consent for.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5 month to collect the sample size and and then the cases will be followed every 2 weeks with Quality of life analysis over the period of one year	the effect of the interventional group will be assessed every 15 days or 2 weeks with QAL Br 30 over the period of 1 year

Secondary Outcome Measures

Name	Time	Method
made attempts at quantifying such changes	towards improvement in quality of life in breast cancer patient

Trial Locations

Locations (1)

Bharati vidyapeeth homoeopathic medical college and hospital pune; 🇮🇳 Pune, MAHARASHTRA, India

Bharati vidyapeeth homoeopathic medical college and hospital pune

🇮🇳Pune, MAHARASHTRA, India

Dr Varada Vishal Phule

Principal investigator

8976188888

drvaradaphule@gmail.com